These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT. Schillaci O, Spanu A, Scopinaro F, Monteleone F, Solinas ME, Volpino P, Pirina P, Marongiu P, Cangemi V, Madeddu G. J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410 [Abstract] [Full Text] [Related]
24. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor. Liu Y, Lan X, Wu T, Lang J, Jin X, Sun X, Wen Q, An R. Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147 [Abstract] [Full Text] [Related]
30. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors. Okarvi SM, Al Jammaz I. Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867 [Abstract] [Full Text] [Related]
31. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342). Zhang J, Zhao X, Wang S, Wang N, Han J, Jia L, Ren X. Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223 [Abstract] [Full Text] [Related]
34. (99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer. Chen B, Zhao G, Ma Q, Ji B, Ji T, Xin H, Gao S. Int J Clin Exp Pathol; 2015 Jun; 8(12):16064-72. PubMed ID: 26884883 [Abstract] [Full Text] [Related]
36. Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations. Herlin G, Kölbeck KG, Menzel PL, Svensson L, Aspelin P, Capitanio A, Axelsson R. Acta Radiol; 2009 Oct; 50(8):902-8. PubMed ID: 19707908 [Abstract] [Full Text] [Related]
37. Tricine co-ligand improved the efficacy of 99mTc-HYNIC-(Ser)3-J18 peptide for targeting and imaging of non-small-cell lung cancer. Shaghaghi Z, Abedi SM, Hosseinimehr SJ. Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901 [Abstract] [Full Text] [Related]
38. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer. Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S. J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221 [Abstract] [Full Text] [Related]
39. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression. Shih CM, Shiau YC, Wang JJ, Ho ST, Kao A. Lung; 2003 Mar; 181(2):103-11. PubMed ID: 12953149 [Abstract] [Full Text] [Related]